Delivery Order SPE2DB22D1002-SPE2DB25FLHS5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.80 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (100 count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single shipment of this immunosuppressant medication, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,951.06 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with an ultimate completion date of May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, valued at $67,741.38, was competitively awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen will perform the work at its corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $583 to Amerisourcebergen Drug Corporation for tacrolimus 1 mg capsules. Under the terms of the award, Amerisourcebergen will provide 100 capsules of the immunosuppressant drug to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 11-12, 2023. The award was made on a firm-fixed-price...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,309.12 on August 13, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units. This is a firm fixed price contract with no set-aside designation, awarded competitively through the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide Tacrolimus 1 mg capsules, an immunosuppressant drug, in 100-count unit doses. The contract has a potential value of $1,382.94 and a completion date of January 3, 2024. This delivery order is part of a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,512.26 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1mg in quantities of 100 units. The contract, awarded on August 7, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHS5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date is scheduled for September 17, 2025, and the product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs across the Defense Department and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for immunosuppressant medication is consistent with the company's role as a critical vendor in the military medical supply chain, fulfilling the Defense Health Agency's pharmaceutical requirements through the DLA Troop Support Medical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/16/25 |